Prognostic value of UPA, PAI-1, and PAI-2 mRNA expression in primary breast cancer.

被引:0
|
作者
Spyratos, F
Bouchet, C
Tozlu, S
Labroquère, M
Vignaud, S
Becette, V
Lidereau, R
Bièche, I
机构
[1] Ctr Rene Huguenin, St Cloud, France
[2] Fac Sci Pharmaceut & Biol Paris, Genet Mol Lab, Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
323
引用
收藏
页码:262 / 262
页数:1
相关论文
共 50 条
  • [31] Abnormal expression of uPA and PAI-1 in lymphangioleiomyomatosis
    Zhe, X
    Schuger, L
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 424A - 424A
  • [32] uPA/PAI-1 expression and uPA promoter methylation in meningiomas
    Julia Annabel Kandenwein
    Tjoung-Won Park-Simon
    Johannes Schramm
    Matthias Simon
    Journal of Neuro-Oncology, 2011, 103 : 533 - 539
  • [33] uPA/PAI-1 expression and uPA promoter methylation in meningiomas
    Kandenwein, Julia Annabel
    Park-Simon, Tjoung-Won
    Schramm, Johannes
    Simon, Matthias
    JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (03) : 533 - 539
  • [34] Influence of preoperative core biopsies on uPA/PAI-1 expression in breast cancer tissue
    Susanne Haas
    Tjoung-Won Park
    Jens Claus Hahne
    Hans-Peter Fischer
    Virchows Archiv, 2008, 452 : 277 - 283
  • [35] Differential Prognostic Impact of uPA and PAI-1 in Colon and Rectal Cancer
    Langenskiold, Marcus
    Holmdahl, Lena
    Angenete, Eva
    Falk, Peter
    Nordgren, Svante
    Ivarsson, Marie-Louise
    TUMOR BIOLOGY, 2009, 30 (04) : 210 - 220
  • [36] PLASMINOGEN-ACTIVATOR INHIBITORS (PAI-1 AND PAI-2) IN LEUKEMIA
    BENNETT, B
    MOORE, NR
    REITH, A
    CROLL, A
    BOOTH, NA
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1274 - 1274
  • [37] Influence of preoperative core biopsies on uPA/PAI-1 expression in breast cancer tissue
    Haas, Susanne
    Park, Tjoung-Won
    Hahne, Jens Claus
    Fischer, Hans-Peter
    VIRCHOWS ARCHIV, 2008, 452 (03) : 277 - 283
  • [38] Plasminogen activator inhibitors (PAI-1 and PAI-2) in human placenta
    Uszynski, M
    Maciejewski, K
    THROMBOSIS AND HAEMOSTASIS, 1999, : 845 - 846
  • [39] Prognostic significance of urokinase plasminogen activator (uPA) and its inhibitor (PAI-1) in breast cancer
    Vrbanec, D.
    Jelisavac-Cosic, S.
    Jakic-Razumovic, J.
    Mustac, E.
    Kuzmic-Prusac, I.
    EJC SUPPLEMENTS, 2004, 2 (03): : 180 - 181
  • [40] Prognostic significance of uPA and PAI-1 in relation to other prognosticators for the clinical outcome of breast cancer
    Knoop, AS
    Laenkholm, AV
    Hansen, S
    Andersen, J
    Andreasen, PA
    Anderson, JA
    Overgaard, J
    Rose, C
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 648 - 648